» Articles » PMID: 23791351

Age- and Gender-related Changes in Ventricular Performance in Wild-type FVB/N Mice As Evaluated by Conventional and Vector Velocity Echocardiography Imaging: a Retrospective Study

Overview
Specialty Radiology
Date 2013 Jun 25
PMID 23791351
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Detailed studies in animal models to assess the importance of aging animals in cardiovascular research are rather scarce. The increase in mouse models used to study cardiovascular disease makes the establishment of physiologic aging parameters in myocardial function in both male and female mice critical. Forty-four FVB/N mice were studied at multiple time points between the ages of 3 and 16 mo using high-frequency echocardiography. Our study found that there is an age-dependent decrease in several systolic and diastolic function parameters in male mice, but not in female mice. This study establishes the physiologic age- and gender-related changes in myocardial function that occur in mice and can be measured with echocardiography. We report baseline values for traditional echocardiography and advanced echocardiographic techniques to measure discrete changes in cardiac function in the commonly employed FVB/N strain.

Citing Articles

The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction.

Du J, Liu J, Wang X, Wang X, Ma Y, Zhang S Biol Direct. 2025; 20(1):28.

PMID: 40065410 PMC: 11895175. DOI: 10.1186/s13062-025-00618-x.


Sex differences in cardiac energetics in the rat ventricular muscle.

Rahmani M, Pham T, Crossman D, Tran K, Taberner A, Han J Sci Rep. 2024; 14(1):31242.

PMID: 39732777 PMC: 11682250. DOI: 10.1038/s41598-024-82604-3.


Biological sex, sex steroids and sex chromosomes contribute to mouse cardiac aging.

Morin-Grandmont A, Walsh-Wilkinson E, Labbe E, Thibodeau S, Dupont E, Boudreau D Aging (Albany NY). 2024; 16(9):7553-7577.

PMID: 38742935 PMC: 11131996. DOI: 10.18632/aging.205822.


Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery.

Gao S, Liu X, Li T, Chen L, Feng Y, Wang Y Acta Pharmacol Sin. 2023; 45(1):23-35.

PMID: 37644131 PMC: 10770177. DOI: 10.1038/s41401-023-01152-0.


The double-hit protocol induces HFpEF and impairs myocardial ubiquitin-proteasome system performance in FVB/N mice.

Lira J, Guymon A, Yang L, Sternburg J, Giri S, Wang X Front Physiol. 2023; 14:1208153.

PMID: 37362441 PMC: 10285383. DOI: 10.3389/fphys.2023.1208153.


References
1.
Du Toit E, Genade S, Carlini S, Moolman J, Brunner F, Lochner A . Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur J Pharmacol. 2006; 556(1-3):115-20. DOI: 10.1016/j.ejphar.2006.11.004. View

2.
Jurcut R, Wildiers H, Ganame J, Dhooge J, Paridaens R, Voigt J . Detection and monitoring of cardiotoxicity-what does modern cardiology offer?. Support Care Cancer. 2008; 16(5):437-45. DOI: 10.1007/s00520-007-0397-6. View

3.
Rajan S, Jagatheesan G, Karam C, Alves M, Bodi I, Schwartz A . Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform. Circulation. 2010; 121(3):410-8. PMC: 2822663. DOI: 10.1161/CIRCULATIONAHA.109.889725. View

4.
Bujak M, Kweon H, Chatila K, Li N, Taffet G, Frangogiannis N . Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol. 2008; 51(14):1384-92. PMC: 3348616. DOI: 10.1016/j.jacc.2008.01.011. View

5.
Betsuyaku T, Kovacs A, Saffitz J, Yamada K . Cardiac structure and function in young and senescent mice heterozygous for a connexin43 null mutation. J Mol Cell Cardiol. 2002; 34(2):175-84. DOI: 10.1006/jmcc.2001.1499. View